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Smoking before the birth of a first child is not associated with
increased risk of breast cancer: findings from the British Women’s
Heart and Health Cohort Study and a meta-analysis
DA Lawlor*,1, S Ebrahim1 and G Davey Smith1
1Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Rd, Bristol BS7 8QA, UK
It has been suggested that the period between puberty and first birth is a time when the breast is particularly susceptible to
carcinogenic effects. In a cohort of 3047 women aged 60–79 years (N¼ 139 breast cancer cases), we found no association between
smoking before the birth of a first child and breast cancer risk: fully adjusted (for age, number of children, age at birth of first child, age
at menarche, age at menopausal, hysterectomy and/or oophorectomy, ever use of oral contraception, use of hormone replacement
therapy, alcohol consumption, body mass index, childhood and adulthood social class) odds ratio 1.06 (95% confidence interval: 0.72,
1.56). The pooled estimate from a meta-analysis of our study and 11 previously published studies (N¼ 6528 cases) was 1.07 (0.94,
1.22). We conclude that smoking prior to the birth of a first child is not associated with increased risk of breast cancer.
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It has been suggested that smoking may play differing roles in the
aetiology of breast cancer depending upon the period in a woman’s
life during which she smokes (Terry and Rohan, 2002). Breast
tissue may be most susceptible to environmental carcinogens
during rapid cell proliferation and before complete cellular
differentiation, that is, between puberty and completion of a
woman’s first pregnancy. This suggestion is supported by the fact
that older age at menarche and early age at first pregnancy, both of
which will decrease the length of this susceptible period, are
associated with reduced risk of breast cancer (MacMahon et al,
1970; Hsieh et al, 1990).
A small number of studies that have assessed the association of
smoking prior to completion of first pregnancy with breast cancer
and have reported conflicting results (Terry and Rohan, 2002). We
aimed to assess this association in a large cohort study and in a
meta-analysis of all previously published studies.
MATERIALS AND METHODS
British Women’s Heart and Health Cohort Study
Data from the baseline assessment and first 3 years of follow-up of
the British Women’s Heart and Health study were used. Full details
of baseline assessment have been reported previously (Lawlor et al,
2003a, b). In brief, 4286 women were assessed (medical record
review, research nurse interview, self-completed questionnaire and
physical examination) between 1999 and 2001. These women have
been followed up over a median of 3.5 years by flagging with the
NHS central register for mortality and cancer register data, two
yearly review of their primary-care medical records (in Britain
primary-care records contain details of secondary-care treatment)
and a recently mailed 3-year follow-up health questionnaire (Q3)
sent to all surviving participants between March and September
2003. Of the 4108 survivors, 3704 (90%) responded to this
questionnaire. Ethics committee approval was obtained for this study.
Breast cancer cases
In this paper, we have included all cases of breast cancer reported
at baseline assessment (prevalent cases) and those occurring over
the median 3.5 years follow-up period (incident cases). Three main
sources were used to determine breast cancer status: (i) self-report
in the baseline questionnaire and Q3; (ii) a diagnosis recorded in
the medical records and (iii) all participants were flagged with the
National Health Service central register (NHSCR) that provided
details of cancer registrations. Anyone with a diagnosis of breast
cancer from any one of these three sources was considered to be a
case. Five additional incident cases that had not been identified by
any of these three sources were obtained because they occurred as
the underlying cause or elsewhere on the woman’s death certificate.
Thus, this study is of prevalent and incident breast cancer cases
occurring any time in the woman’s life up to January 2004.
Assessment of smoking and potential covariates
Age at menopause, age at menarche, number of pregnancies and
live births, current and past use of hormone replacement therapy
(HRT) and past use of oral contraception, history of a
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hysterectomy and/or oophorectomy, alcohol and smoking history
were obtained from the self-completed questionnaire and/or the
research nurse interview (Lawlor et al, 2003a, b). Detailed smoking
histories included the age at which smoking started. Adult social
class was defined on the basis of the longest held occupation of her
husband for married women and her own longest held occupation
for single women, childhood social class was defined on the basis
of the longest held occupation of the participants father, and both
were classified according to the Registrar General’s classification
(Office of Population Censuses and Surveys, 1980). Standing height
was measured without shoes using a Harpenden Stadiometer,
which recorded to the nearest millimetre. Weight was measured in
light clothing without shoes to the nearest 0.1 kg using Soenhle
portable scales.
Statistical analysis
Multiple logistic regression was used to assess the association
between smoking in relation to first birth and breast cancer with
adjustment for potential confounding factors: age (entered as a
continuous variable), age at first birth (indicator:o20, 21–24, 25–
29, 30–34, X35), age at menarche (indicator: o11, 11, 12, 13, 14,
X15), number of births (indicator: 1, 2, 3, 4, 5, 6þ ), age at
menopause (indicator: o40, 41–44, 45– 49, 50, 51, older than 51),
use of HRT (ever or never), hysterectomy and/or oophotectomy
(binary), childhood and adult social class (indicator: I, II,
IIInonmanual, IIImanual, IV, V, unemployed), body mass index
(BMI) (continuous) and alcohol consumption (indicator: daily,
weekends only, once or twice a month, special occasions, never).
To further explore whether smoking around the time of breast
development was a risk factor for future breast cancer, we assessed
the association of smoking during the period 1 year before
menarche and the first 5 years after menarche in all women using
multiple logistic regression. For all analyses robust standard
errors, which take into account possible nonindependence between
women from the same town, were used to calculate confidence
intervals (CI) and P-values.
Meta-analysis
Searches of Medline and Embase (up to January 2004) were
undertaken using extended terms for breast neoplasia and
smoking. Any published study that assessed the association
between smoking before a first pregnancy and breast cancer risk
was included in a meta-analysis. We decided a priori to pool
estimates using DerSimonian and Laird’s random effects methods,
since it was likely that there would be heterogeneity between
studies due to differences in the number of pre- and postmeno-
pausal cases and differences in study design (DerSimonian and
Laird, 1986). Metaregression analysis was used to assess the effect
of menopausal status on heterogeneity between studies (Sterne
et al, 2001). A series of sensitivity analyses were undertaken in
which: (i) two studies with in-pregnancy smoking assessment only
were excluded; (ii) one study with smoking only before pregnancy
was excluded; (iii) for studies that provided estimates of both any
smoking before pregnancy and only smoking before pregnancy,
the latter estimates were substituted into the main analysis; (iv) for
studies with varying durations of smoking before pregnancy these
were substituted into the main analysis starting first with shortest
duration. We examined funnel plots and used Egger and Begg tests
to determine the extent of small study bias. (Sterne et al, 2001) All
statistical analyses were undertaken using Stata version 8.
RESULTS
Of the 4286 women in this study, 225 (5.3%) had breast cancer
ascertained from at least one source. The majority (82%) of these
cases were identified from at least two sources. The age
distribution of women with cancer identified by each source were
similar – mean (standard deviation) age of women with breast
cancer identified by self report 68.7 (5.3), identified by medical
record review 68.9 (5.3) and identified by cancer register 69.0 (5.4).
Of the 225 cases, 170 were prevalent and 55 incident cases.
Table 1 shows the distributions of established breast cancer risk
factors and other potential risk factors by breast cancer status
among all 4286 women. For established risk factors, our results are
in the same direction and of similar magnitudes to what one would
expect based on consistent results from previous studies. None of
the smoking alcohol or social class variables were associated with
breast cancer.
Smoking prior to first birth
Of the 4286 women, 3467 (81%) had at least one live birth and of
these 3047 (88%) gave their age at the time that their first child was
born. The associations presented in Table 1 were similar in this
subgroup of 3047 women. Of these 3047 women, 139 (4.6%) had
breast cancer. Table 2 shows breast cancer occurrence and the
distributions of potential confounding factors by smoking in
Table 1 Smoking and other characteristics irrespective of whether women had breast cancer or not (N¼ 4286)
Percent (95% CI)
Breast cancer N¼ 225 No breast cancer N¼ 4061 P-value
Ever smoked 43.1 (36.5, 49.9) 44.8 (43.2, 46.3) 0.63
Current smoker (at baseline assessment) 11.6 (7.7, 16.5) 12.0 (11.0, 13.1) 0.84
Smoked prior to first birtha 32.1 (24.5, 40.6) 30.5 (28.9, 32.2) 0.68
Smoked either 1 year before or within 5 years after menarcheb 25.6 (19.2, 32.8) 26.3 (24.7, 27.9) 0.84
Nulliparous 13.8 (9.4, 19.3) 9.5 (8.6, 10.5) 0.04
Young age and menarche (o11 years) 4.9 (2.5. 8.6) 2.1 (1.7, 2.6) 0.008
Old age at menopause (451 years) 33.8 (27.6, 40.04) 27.2 (25.9, 28.6) 0.03
Hysterectomy and/or oophorectomy 24.4 (19.0, 30.6) 30.2 (28.8, 31.6) 0.06
Ever used HRT 18.7 (13.8, 24.4) 12.5 (11.5, 13.6) 0.007
Ever used oral contraception 25.4 (19.7, 31.7) 23.9 (22.2, 24.9) 0.53
Childhood manual social class 81.3 (75.6, 86.2) 80.0 (78.7, 81.1) 0.61
Adult manual social class 55.1 (48.4, 61.7) 57.4 (55.9, 58.9) 0.49
Over weight (BMI 425) 71.4 (64.8, 77.1) 67.9 (66.4, 69.4) 0.30
Daily alcohol consumption 21.0 (15.8, 27.1) 18.1 (16.9, 19.4) 0.29
Tee-total 17.8 (12.9, 23.5) 16.5 (15.3, 17.7) 0.63
BMI¼ body mass index; HRT¼ hormone replacement therapy; CI¼ confidence interval. aOnly among those with at least one child and compared to never smokers¼ 139 cases
(see text). bIrrespective of whether they had children or not and compared to never smokers.
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relation to first birth. There was no association between breast
cancer and smoking in relation to first birth. The age-adjusted
odds ratio for smoking before the first birth was 1.04 (95% CI: 0.71,
1.51) and the fully adjusted (age, number of children, menarcheal
and menopausal age, hysterectomy, use of hormone replacement,
use of the oral contraceptive pill, childhood and adulthood social
class and BMI) odds ratio was 1.06 (0.72, 1.56). When the analyses
were restricted to those who only smoked before their first
pregnancy (ie excluding from the analyses all women who smoked
but only began after their first birth), the association was
essentially unchanged: fully adjusted odds ratio 1.04 (0.67, 1.59).
The age-adjusted odds ratios for women who smoked, but only
after the birth of their first child compared to never smokers, was
0.79 (0.44, 1.41) and the fully adjusted odds ratio for this
association was 0.70 (0.36, 1.36).
Smoking around the time of puberty
Among all women in the cohort (4286 women with 225 cases of
breast cancer), the age-adjusted odds ratio for smoking either in
the year prior to or within 5 years of menarche compared to never
smoking was 0.96. (0.69, 1.36); the fully adjusted odds ratio was
1.00 (0.70, 1.39).
Sensitivity analyses
In the whole cohort, 186 (83%) of the total 225 cases were
postmenopausal and in the subgroup of women with at least one
birth and a known age at first birth 118 (85%) of the 139 breast
cancers were postmenopausal. We were therefore unable to
determine with any level of precision the effect of associations
on premenopausal cancers. The associations for postmenopausal
breast cancers only did not differ from those presented and the
point estimates for premenopausal cancers were similar to those
for postmenopausal cancers and close to the null value (point
estimate for premenopausal cancers associated with smoking prior
to first birth¼ 0.96, and for smoking around the time of
puberty¼ 0.94). When the analyses were restricted to incident
cases only, although considerably less precise, the results did not
differ from those presented: fully adjusted odds ratio 1.08 (0.39,
Table 2 Breast cancer and other characteristics by smoking in relation to birth of first child among women with at least one live birth and who provided
age at first birth (N¼ 3047)
Percent (95% CI)
Never smoked N¼1739 Smoked before first birth N¼ 933 Smoked but only after first birth N¼ 376 P-value
Breast cancer 4.7 (3.8, 5.8) 4.8 (3.6, 6.4) 3.7 (2.2, 6.2) 0.66
Young age and menarche (o11 years) 2.2 (1.6, 3.0) 2.1 (1.4, 3.3) 2.1 (1.1, 4.2) 0.99
Old age at menopause (451 years) 32.1 (29.9, 34.3) 28.4 (25.6, 31.4) 22.1 (18.2, 26.5) o0.001
Hysterectomy and/or oophorectomy 30.9 (28.8, 33.2) 29.3 (26.4, 32.3) 34.6 (29.9, 39.5) 0.17
Ever used HRT 13.4 (11.9, 15.1) 16.6 (14.4, 19.1) 12.8 (9.8, 16.5) 0.05
Ever used oral contraception 23.9 (21.9, 26.0) 31.4 (28.5, 34.5) 28.4 (23.8, 33.4) o0.001
Childhood manual social class 78.9 (76.9, 80.8) 79.4 (76.7, 81.9) 84.3 (80.3, 87.6) 0.05
Adult manual social class 55.4 (53.0, 57.7) 55.3 (52.1, 58.5) 65.4 (60.5, 70.1) 0.001
Over weight (BMI X25) 69.7 (67.4, 71.8) 66.2 (63.0, 69.3) 73.9 (68.9, 78.3) 0.03
BMI¼ body mass index; HRT¼ hormone replacement therapy; CI¼ confidence interval.
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Figure 1 Meta-analysis of studies assessing the effect of smoking before/during first pregnancy with breast cancer risk.
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Table 3 Summary of studies assessing the association of smoking prior to the birth of a first baby and breast cancer risk
Study Study type
Age at
ascertainment/
menopausal status
Number of
cases
Number of
controls Comparisons OR (95% CI)
Adjusted/matched
for
Adami et al (1988) PCC o45 years over 90%
premenopausal
363 454 1–4 years before
1st pregnancy vs
never
1.0 (0.6, 1.6) Age, education, age at
menarche, age at
pregnancy, menopause,
benign disease, family
history, oral
contraceptive use,
alcohol consumption
5–9 years before
vs never
0.7 (0.4, 1.1)
10+ years before vs
never
0.7 (0.3, 1.4)
Any smoking
before vs nevera
0.81 (0.59, 1.12)a
Hunter et al (1997) NCC Mean age 57.6 60%
postmenopausal
417 412 1–5 years before
1st pregnancy vs
never
1.9 (1.2, 2.8) Year of birth,
menopausal status,
HRT, age menarche,
age first birth, family
history, benign disease
5+ years before vs
never
1.1 (0.8, 1.6)
Any smoking
before vs nevera
1.36 (0.84, 2.43)a
Lash et al (1999) PCC 90% postmenopausal 44 145 Only smoked
before vs never
5.6 (1.5, 21) Age, history of radiation
therapy, BMI, family
history, parity, benign
disease
Innes et al (2001) PCC 26–45 100%
premenopausal
319 768 Smoking during 1st
pregnancy vs not
smoking during 1st
pregnancy
3.0 (1.3, 7.2) Age, maternal age, race
and education
Egan et al (2002) PCh f-u 14
years only
includes
incident cases
Over 60%
postmenopausal
1288 70 663 Any smoking
before vs never
1.12 (0.96, 1.31)b Age, age at menarche,
age at first birth, benign
disease, family history,
menopausal status, age
at menopause, weight
at age 18 and adult
change in weight, adult
height, alcohol,
carotenoid intake, HRT
use
Only smoked
before vs never
1.18 (0.95, 1.46)b
Band et al, –
postmenopausal
2002
PCC 100% postmenopausal 267 267 Any smoking
before vs never
0.97 (0.76, 1.24) Age, ethnic origin,
marital status,
education, alcohol
consumption, age at
menarche, age at
menopause, family
history, benign disease,
weight and BMI from
age 18 years to
concurrent, oral
contraceptive use, HRT
use, reproductive
history, breast feeding
Band et al (2002)–
premenopausal
PCC 100% premenopausal 113 105 Any smoking
before vs never
1.37 (0.93, 2.01) As above
Lash et al (2002) PCC All ages, proportion
pre- and
postmenopausal not
stated
276 258 Any smoking
before vs never
active or passive
0.69 (0.49, 0.96 Age, radiation therapy,
BMI, family history,
benign disease, alcohol,
parity
Only smoking
before vs never
active or passive
0.73 (0.42, 1.30)
Kropp et al (2002) PCC p50 77%
premenopausal
196 469 Any smoking
before vs never
active or passive
1.32 (0.86, 2.03) Age, study region,
alc0hol, breast feeding,
education, family
Smoking, pregnancy and breast cancer
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2.55). When all analyses were repeated using breast cancer data
from each of just one of the three sources (self-report, medical
records, cancer register), the results were unchanged.
Meta-analysis
We identified 11 studies in 10 publications; these are summarised
in Table 3. (Adami et al, 1988; Hunter et al, 1997; Lash and
Aschengrau, 1999; Innes and Byers, 2001; Egan et al, 2002; Band
et al, 2002; Lash and Aschengrau, 2002; Kropp and Chang-Claude,
2002; Fink and Lash, 2003; Reynolds et al, 2004) The pooled
analysis for these 11 studies, together with the study presented
here, included 6528 breast cancer cases and provided an odds ratio
(95% CI) of 1.07 (0.94, 1.22) (Figure 1). The pooled estimates from
differing sensitivity analyses to assess the effect of different
exposure measures did not differ substantively from this estimate
(all odds ratios for these analyses were between 1.05 and 1.08).
There was heterogeneity between the studies (P¼ 0.01), which was
not explained by menopausal status (P¼ 0.34). The Egger test did
not suggest strong evidence of small study bias (P¼ 0.23),
although the Begg test provided more evidence of this (P¼ 0.07).
The funnel plot (Figure 2) shows the influence of two small studies
with large positive effects on the Begg test result, and examination
of the Forrest plot (Figure 1) suggests that these two studies are an
important source of heterogeneity. When these two studies were
removed from the meta-analysis (leaving N¼ 6165 cases), the
pooled odds ratio (95% CI) was 1.03 (0.93, 1.14) with no strong
evidence of heterogeneity between studies (P¼ 0.23). Other than
being two of the smallest and least precise studies, it can be seen
from Table 3 that there is nothing that makes these two studies
specifically different from all other studies.
DISCUSSION
Our results suggest that there is no association between a woman
smoking before the birth of her first child and breast cancer. Our
finding that smoking around the time of puberty was not
associated with increased risk of breast cancer is consistent with
a number of other studies.(O’Connell et al, 1987; Rohan and Baron,
1989; Chu et al, 1990; Ewertz, 1990, 1993; Field et al, 1992; Smith
et al, 1994; Baron et al, 1996; Band et al, 2002) Taken together,
these findings suggest that smoking during the period of breast
tissue development and before final cellular differentiation (ie
before completion of a first pregnancy) is not associated with
breast cancer.
history, menopausal
status, BMI
Only smoking
before vs never
active or passive
0.92 (0.52, 1.65)
Fink et al (2003) PCC 25–55 menopausal
status not given
1665 4972 Smoking during
pregnancy vs not
smoking during
pregnancy
0.97 (0.80, 1.2) Age, education, race,
parity, history of
terminations.
Reynolds et al
(2004)
PCh 5 years f-u
only includes
incident cases
75% postmenopausal at
baseline
1441 Approx 100 000 o5 years before
1st pregnancy vs
never
0.99 (0.80, 1.21)b Age, race, family
history, age menarche,
age first pregnancy,
physical activity, alcohol,
BMI, menopausal status,
BMImenopause
interaction, HRT
X5 years before vs
never
1.13 (1.00, 1.28)b
Any smoking
before vs nevera
1.08 (0.96, 1.22)a
Lawlor et al (2004,
this study)
PCh 3 years f-u
includes
incident and
prevalent cases
60–82 85%
postmenopausal
139 2908 Ever smoking
before vs never
1.06 (0.72, 1.56) Age, age at first birth,
number of children, age
menarche, age
menopause,
hysterectomy and/or
oophorectomy, ever
use of oral
contraception, use of
hormone replacement
therapy, alcohol
consumption, BMI,
childhood and
adulthood social class
Only smoking
before vs never
1.04 (0.68, 1.57)
OR: odds ratio; CI: confidence interval; NCC: nested case–control – this study was nested in a population, prospective cohort; PCC: population-based case–control; PCh:
population cohort; HRT: hormone replacement therapy, BMI: body mass index; f-u: follow-up. aNot provided in the paper but calculated from the data provided – these values
used in meta-analysis. bHazard ratios.
Table 3 (Continued)
Study Study type
Age at
ascertainment/
menopausal status
Number of
cases
Number of
controls Comparisons OR (95% CI)
Adjusted/matched
for
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Study limitations
The majority of our cases were prevalent and survivor bias may be
an important limitation. Breast cancer in the UK is associated with
a survival rate of 70% over 5 years (Coleman et al, 1999). Our
study, and other case–control studies of this association, may
therefore exclude a number of women with aggressive disease. If
smoking prior to first birth is strongly associated with survival,
then we may have missed an important association. However, two
prospective studies of incident cases only did not find an
association (Egan et al, 2002; Reynolds et al, 2004), and when we
restricted our analyses to incident cases only, although imprecise
there was no evidence of an association.
Breast cancer cases were not confirmed histologically and self-
reported breast cancer may be inaccurate. However, over 80% of
the cases were identified from at least two sources, including
medical records, cancer registers or self-report. Medical record
and cancer register cases are likely to have been confirmed by
histological reports and when sensitivity analyses were performed
using breast cancer data from each of just one of the three sources
(cancer register, general practice medical records, self-report) the
results were unchanged. By combining information from all three
sources, it is likely that most cases have been identified.
An important limitation of our, and other, studies is the small
number of cases and hence imprecision of the results. This
highlights the importance of pooling results from all studies in
order to provide a precise estimate of the overall effect.
Smoking after first birth
Although imprecise and not an a priori hypothesis, our results
suggest that smoking solely after a woman’s first birth may be
protective against breast cancer. Two other studies have also found
reduced risk of breast cancer associated with smoking only in the
period after a first birth (Band et al, 2002; Lash and Aschengrau,
2002). Some compounds in cigarettes inhibit the aromatisation of
androgens to oestrogens and enhance the formation of oestrodiol
metabolites with low oestrogenic activity (Michnovicz et al, 1986;
Kadohama et al, 1993). Hence it has been suggested that smoking
in later life may be associated with reduced risk of breast cancer
through mechanisms related to decreased oestrogen activity (Band
et al, 2002). However, results in this area have been inconsistent
with two studies finding increased risk of breast cancer among
women who begin smoking only after the birth of their first child
(Lash and Aschengrau, 1999; Kropp and Chang-Claude, 2002), and
two prospective studies found no association (Egan et al, 2002;
Reynolds et al, 2004).
CONCLUSION
Smoking around the time of breast tissue development and before
full differentiation – between puberty and prior to completion of
the first pregnancy – is not associated with increased risk of breast
cancer. Smoking is associated with a number of adverse health
outcomes and young women should be discouraged from taking
up smoking irrespective of any association or lack of association
with breast cancer.
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